Correction to: Nature https://doi.org/10.1038/s41586-021-04246-z Published online 22 December 2021
In the version of this article initially published, there was an error in column B, row 1 in Supplementary Table 1, where the unit incorrectly appeared as IC50 (μM) instead of IC50 (nM). In addition, we noticed that there was an image duplication of Extended Data Fig. 10h, where the image of SMARCA4/BRG1 IHC staining of kidney tissue from the enzalutamide group was inadvertently duplicated from the vehicle group. The conclusions of the paper remain unaffected. Supplementary Table 1 and Extended Data Fig. 10h have been updated to reflect these revisions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xiao, L., Parolia, A., Qiao, Y. et al. Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer. Nature 629, E9 (2024). https://doi.org/10.1038/s41586-024-07393-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-024-07393-1
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.